[Cardiovascular disease in times of COVID-19].
Identifieur interne : 000021 ( Main/Exploration ); précédent : 000020; suivant : 000022[Cardiovascular disease in times of COVID-19].
Auteurs : Pablo Lamelas [Argentine, Canada] ; Fernando Botto [Argentine] ; Gustavo Pedernera [Argentine] ; Alberto Alves De Lima [Argentine] ; Juan Pablo Costabel [Argentine] ; Jorge Belardi [Argentine]Source :
- Medicina [ 1669-9106 ] ; 2020.
Descripteurs français
- KwdFr :
- Argentine (épidémiologie), Betacoronavirus (MeSH), Charge mondiale de morbidité (MeSH), Facteurs de risque (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Maladies cardiovasculaires (mortalité), Maladies cardiovasculaires (prévention et contrôle), Mâle (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Prévalence (MeSH).
- MESH :
- mortalité : Maladies cardiovasculaires.
- prévention et contrôle : Infections à coronavirus, Maladies cardiovasculaires, Pandémies, Pneumopathie virale.
- épidémiologie : Argentine.
- Betacoronavirus, Charge mondiale de morbidité, Facteurs de risque, Femelle, Humains, Mâle, Prévalence.
- Wicri :
- geographic : Argentine.
English descriptors
- KwdEn :
- Argentina (epidemiology), Betacoronavirus (MeSH), Cardiovascular Diseases (mortality), Cardiovascular Diseases (prevention & control), Coronavirus Infections (prevention & control), Female (MeSH), Global Burden of Disease (MeSH), Humans (MeSH), Male (MeSH), Pandemics (prevention & control), Pneumonia, Viral (prevention & control), Prevalence (MeSH), Risk Factors (MeSH).
- MESH :
- geographic , epidemiology : Argentina.
- mortality : Cardiovascular Diseases.
- prevention & control : Cardiovascular Diseases, Coronavirus Infections, Pandemics, Pneumonia, Viral.
- Betacoronavirus, Female, Global Burden of Disease, Humans, Male, Prevalence, Risk Factors.
Abstract
There are increasing reports of a drastic drop in consultations and cardiovascular procedures (including urgencies and emergencies) in regions affected by the COVID-19 pandemic, with a consequent marked increase in total mortality that is not fully explained by COVID-19. Cardiovascular disease leads the ranking in deaths in adults in Argentina with 280 deaths per day, and in recent decades we have reduced its mortality by 20-30% through various evidence-based interventions. Herein we conducted predictive analyses to understand what could be the consequences of a worse implementation of those interventions. We estimate that less control of cardiovascular risk factors from April to October 2020 could cause up to 10 500 new preventable cases of cardiovascular disease. In terms of myocardial infarction, a drop from 40% to 60% of the reperfusion treatment could increase mortality by 3% to 5%. A marginal 10% to 15% increase in relative risk of cardiovascular death would be equivalent to an excess of 6000 to 9000 preventable deaths. In conclusion, given the high prevalence and fatality of cardiovascular disease, even a small negative impact on the efficacy of its care will translate into large numbers of people affected in Argentina. It is necessary to inform the authorities and educate the public so cardiovascular diseases and their risk factors remain a health priority, as long as resources exist and minimizing the risk of contagion and spread of the virus.
PubMed: 32442939
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Cardiovascular disease in times of COVID-19].</title><author><name sortKey="Lamelas, Pablo" sort="Lamelas, Pablo" uniqKey="Lamelas P" first="Pablo" last="Lamelas">Pablo Lamelas</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina. E-mail: plamelas@icba.com.ar.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Botto, Fernando" sort="Botto, Fernando" uniqKey="Botto F" first="Fernando" last="Botto">Fernando Botto</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Pedernera, Gustavo" sort="Pedernera, Gustavo" uniqKey="Pedernera G" first="Gustavo" last="Pedernera">Gustavo Pedernera</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Alves De Lima, Alberto" sort="Alves De Lima, Alberto" uniqKey="Alves De Lima A" first="Alberto" last="Alves De Lima">Alberto Alves De Lima</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Costabel, Juan Pablo" sort="Costabel, Juan Pablo" uniqKey="Costabel J" first="Juan Pablo" last="Costabel">Juan Pablo Costabel</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Belardi, Jorge" sort="Belardi, Jorge" uniqKey="Belardi J" first="Jorge" last="Belardi">Jorge Belardi</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32442939</idno><idno type="pmid">32442939</idno><idno type="wicri:Area/Main/Corpus">000234</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000234</idno><idno type="wicri:Area/Main/Curation">000234</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000234</idno><idno type="wicri:Area/Main/Exploration">000234</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Cardiovascular disease in times of COVID-19].</title><author><name sortKey="Lamelas, Pablo" sort="Lamelas, Pablo" uniqKey="Lamelas P" first="Pablo" last="Lamelas">Pablo Lamelas</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina. E-mail: plamelas@icba.com.ar.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Botto, Fernando" sort="Botto, Fernando" uniqKey="Botto F" first="Fernando" last="Botto">Fernando Botto</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Pedernera, Gustavo" sort="Pedernera, Gustavo" uniqKey="Pedernera G" first="Gustavo" last="Pedernera">Gustavo Pedernera</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Alves De Lima, Alberto" sort="Alves De Lima, Alberto" uniqKey="Alves De Lima A" first="Alberto" last="Alves De Lima">Alberto Alves De Lima</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Costabel, Juan Pablo" sort="Costabel, Juan Pablo" uniqKey="Costabel J" first="Juan Pablo" last="Costabel">Juan Pablo Costabel</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Belardi, Jorge" sort="Belardi, Jorge" uniqKey="Belardi J" first="Jorge" last="Belardi">Jorge Belardi</name><affiliation wicri:level="1"><nlm:affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Instituto Cardiovascular de Buenos Aires, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author></analytic><series><title level="j">Medicina</title><idno type="eISSN">1669-9106</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Argentina (epidemiology)</term><term>Betacoronavirus (MeSH)</term><term>Cardiovascular Diseases (mortality)</term><term>Cardiovascular Diseases (prevention & control)</term><term>Coronavirus Infections (prevention & control)</term><term>Female (MeSH)</term><term>Global Burden of Disease (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (prevention & control)</term><term>Prevalence (MeSH)</term><term>Risk Factors (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Argentine (épidémiologie)</term><term>Betacoronavirus (MeSH)</term><term>Charge mondiale de morbidité (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Maladies cardiovasculaires (mortalité)</term><term>Maladies cardiovasculaires (prévention et contrôle)</term><term>Mâle (MeSH)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Prévalence (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Argentina</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Cardiovascular Diseases</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Maladies cardiovasculaires</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cardiovascular Diseases</term><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Maladies cardiovasculaires</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Argentine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Female</term><term>Global Burden of Disease</term><term>Humans</term><term>Male</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Charge mondiale de morbidité</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Prévalence</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Argentine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There are increasing reports of a drastic drop in consultations and cardiovascular procedures (including urgencies and emergencies) in regions affected by the COVID-19 pandemic, with a consequent marked increase in total mortality that is not fully explained by COVID-19. Cardiovascular disease leads the ranking in deaths in adults in Argentina with 280 deaths per day, and in recent decades we have reduced its mortality by 20-30% through various evidence-based interventions. Herein we conducted predictive analyses to understand what could be the consequences of a worse implementation of those interventions. We estimate that less control of cardiovascular risk factors from April to October 2020 could cause up to 10 500 new preventable cases of cardiovascular disease. In terms of myocardial infarction, a drop from 40% to 60% of the reperfusion treatment could increase mortality by 3% to 5%. A marginal 10% to 15% increase in relative risk of cardiovascular death would be equivalent to an excess of 6000 to 9000 preventable deaths. In conclusion, given the high prevalence and fatality of cardiovascular disease, even a small negative impact on the efficacy of its care will translate into large numbers of people affected in Argentina. It is necessary to inform the authorities and educate the public so cardiovascular diseases and their risk factors remain a health priority, as long as resources exist and minimizing the risk of contagion and spread of the virus.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32442939</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1669-9106</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>3</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Medicina</Title><ISOAbbreviation>Medicina (B Aires)</ISOAbbreviation></Journal><ArticleTitle>[Cardiovascular disease in times of COVID-19].</ArticleTitle><Pagination><MedlinePgn>248-252</MedlinePgn></Pagination><Abstract><AbstractText>There are increasing reports of a drastic drop in consultations and cardiovascular procedures (including urgencies and emergencies) in regions affected by the COVID-19 pandemic, with a consequent marked increase in total mortality that is not fully explained by COVID-19. Cardiovascular disease leads the ranking in deaths in adults in Argentina with 280 deaths per day, and in recent decades we have reduced its mortality by 20-30% through various evidence-based interventions. Herein we conducted predictive analyses to understand what could be the consequences of a worse implementation of those interventions. We estimate that less control of cardiovascular risk factors from April to October 2020 could cause up to 10 500 new preventable cases of cardiovascular disease. In terms of myocardial infarction, a drop from 40% to 60% of the reperfusion treatment could increase mortality by 3% to 5%. A marginal 10% to 15% increase in relative risk of cardiovascular death would be equivalent to an excess of 6000 to 9000 preventable deaths. In conclusion, given the high prevalence and fatality of cardiovascular disease, even a small negative impact on the efficacy of its care will translate into large numbers of people affected in Argentina. It is necessary to inform the authorities and educate the public so cardiovascular diseases and their risk factors remain a health priority, as long as resources exist and minimizing the risk of contagion and spread of the virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamelas</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina. E-mail: plamelas@icba.com.ar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botto</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedernera</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves De Lima</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costabel</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belardi</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Enfermedad cardiovascular en tiempos de COVID-19.</VernacularTitle></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Medicina (B Aires)</MedlineTA><NlmUniqueID>0204271</NlmUniqueID><ISSNLinking>0025-7680</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071219" MajorTopicYN="N">Global Burden of Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>Existen crecientes informes sobre una drástica caída en consultas y realización de procedimientos cardiovasculares (incluyendo urgencias y emergencias) en regiones afectadas por la pandemia de COVID-19, con el consecuente incremento marcado de la mortalidad total que no se explica totalmente por las defunciones atribuidas a COVID-19. En Argentina, la enfermedad cardiovascular lidera el ranking de muertes en adultos con 280 muertes por día, y en las últimas décadas hemos reducido su mortalidad entre 20 y 30% mediante diversas intervenciones basadas en la evidencia. En el presente trabajo realizamos análisis predictivos para entender cuáles podrían ser las consecuencias de una peor implementación de dichas intervenciones. Estimamos que un menor control de los factores de riesgo cardiovascular de abril a octubre de 2020 podría causar hasta 10 500 nuevos casos prevenibles de enfermedad cardiovascular. En términos de infarto de miocardio, una caída del 40% al 60% del tratamiento de reperfusión podría incrementar la mortalidad del 3% al 5%. Un incremento marginal de riesgo relativo de 10% a 15% de muerte cardiovascular equivaldría a un exceso de 6000 a 9000 muertes evitables. En conclusión, dada la alta prevalencia y fatalidad de la enfermedad cardiovascular, incluso un pequeño impacto negativo en la eficacia de su cuidado se traducirá en grandes cantidades de afectados en Argentina. Es necesario informar a las autoridades y educar al público para que sigan controlando enfermedades cardiovasculares y sus factores de riesgo, siempre que existan recursos y minimizando el riesgo de contagio y propagación del virus.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32442939</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Argentine</li><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Hamilton (Ontario)</li></settlement><orgName><li>Université McMaster</li></orgName></list><tree><country name="Argentine"><noRegion><name sortKey="Lamelas, Pablo" sort="Lamelas, Pablo" uniqKey="Lamelas P" first="Pablo" last="Lamelas">Pablo Lamelas</name></noRegion><name sortKey="Alves De Lima, Alberto" sort="Alves De Lima, Alberto" uniqKey="Alves De Lima A" first="Alberto" last="Alves De Lima">Alberto Alves De Lima</name><name sortKey="Belardi, Jorge" sort="Belardi, Jorge" uniqKey="Belardi J" first="Jorge" last="Belardi">Jorge Belardi</name><name sortKey="Botto, Fernando" sort="Botto, Fernando" uniqKey="Botto F" first="Fernando" last="Botto">Fernando Botto</name><name sortKey="Costabel, Juan Pablo" sort="Costabel, Juan Pablo" uniqKey="Costabel J" first="Juan Pablo" last="Costabel">Juan Pablo Costabel</name><name sortKey="Pedernera, Gustavo" sort="Pedernera, Gustavo" uniqKey="Pedernera G" first="Gustavo" last="Pedernera">Gustavo Pedernera</name></country><country name="Canada"><region name="Ontario"><name sortKey="Lamelas, Pablo" sort="Lamelas, Pablo" uniqKey="Lamelas P" first="Pablo" last="Lamelas">Pablo Lamelas</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000021 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000021 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32442939
|texte= [Cardiovascular disease in times of COVID-19].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32442939" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |